Pelthos Therapeutics Inc. - PTHS
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$21.49M
QoQ value delta ($000)
-$6.388M
(-22.92%)
Implied price effect (QoQ)
-29.79%
Shares
Total shares
987,331
QoQ shares delta
+87,972
(+9.78%)
Total shares held by funds (by quarter)
Market chart (PTHS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 17 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Murchinson Ltd. | 6,225 | 296,314 | 0.79% |
| Ikarian Capital, LLC | 5,391 | 256,598 | 0.44% |
| VANGUARD GROUP INC | 2,325 | 75,020 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,955 | 93,093 | 0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,719 | 81,858 | 0.02% |
| J. Goldman & Co LP | 1,059 | 50,415 | 0.03% |
| CANTOR FITZGERALD, L. P. | 870 | 41,423 | 0.01% |
| DIADEMA PARTNERS LP | 520 | 24,773 | 0.09% |
| Knott David M Jr | 442 | 21,073 | 0.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 321 | 15,290 | 0.0% |
| Pale Fire Capital SE | 271 | 12,919 | 0.02% |
| VANGUARD FIDUCIARY TRUST CO | 206 | 9,817 | 0.0% |
| Persistent Asset Partners Ltd | 126 | 6,007 | 0.05% |
| Steward Partners Investment Advisory, LLC | 40 | 1,910 | 0.0% |
| UBS Group AG | 16 | 764 | 0.0% |
| CITIGROUP INC | 0 | 1 | 0.0% |
| Aspect Partners, LLC | 0 | 16 | 0.0% |
| Farther Finance Advisors, LLC | 0 | 40 | 0.0% |